Publication | Closed Access

Docosahexaenoic acid (DHA) inhibits pro-angiogenic effects of breast cancer cells via down-regulating cellular and exosomal expression of angiogenic genes and microRNAs

Docosahexaenoic AcidBreast OncologyOncologyAngiogenesisMedicineBreast Cancer CellsPharmacologyExosomal ExpressionVascular BiologyBreast CancerAnti-cancer AgentRadiation OncologyCancer BiologyCell BiologyCancer ResearchTumor Biology